New sensitive tools for hepatitis B virus (HBV) detection in liver transplantation: What will be their impact on the prophylaxis of HBV infection?
Didier Samuel, Anne Marie Roque‐Afonso – 30 July 2007
Reply to: Selecting patients with hepatocellular carcinoma for transplantation
Gerd Otto – 30 July 2007
Reply to: Which is the best timing of bile duct division in living liver donor surgery?
Silvio Nadalin, Giuliano Testa – 30 July 2007
An artificial vascular graft is a useful interpositional material for drainage of the right anterior section in living donor liver transplantation
Nam‐Joon Yi, Kyung‐Suk Suh, Hae Won Lee, Eung‐Ho Cho, Woo Young Shin, Jai Young Cho, Kuhn Uk Lee – 30 July 2007 – Congestion in the anterior section in a right liver (RL) without a middle hepatic vein (MHV) may lead to graft dysfunction. To solve this problem, an RL draining MHV branches with autologous or cryopreserved vessels can be introduced. However, these vessels are often unavailable, and their preparation is time‐consuming. An expanded polytetrafluoroethylene (ePTFE) graft may be used for anterior section drainage.
Living donor liver transplantation for children in Brazil weighing less than 10 kilograms
Joao Seda Neto, Eduardo Carone, Vincenzo Pugliese, Alcides Salzedas, Eduardo A. Fonseca, Hsiang Teng, Gilda Porta, Renata Pugliese, Irene Miura, Vera Baggio, Massami Hayashi, Marcos Beloto, Teresa Guimaraes, Andre Godoy, Mario Kondo, Paulo Chapchap – 30 July 2007 – Infants with end‐stage liver disease represent a treatment challenge. Living donor liver transplantation (LDLT) is the only option for timely liver transplantation in many areas of the world, adding to the technical difficulties of the procedure.
Why we did not use this donor
Cihan Duran, Burcin Taner, Murat Dayangac, Baris Akin, Deniz Balci, Zahide Kurt, Refik Killi, Yildiray Yuzer, Yaman Tokat – 30 July 2007
Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular events
Marie Laryea, Kymberly D. Watt, Michele Molinari, Mark J. Walsh, Vivian C. McAlister, Paul J. Marotta, Bjorn Nashan, Kevork M. Peltekian – 30 July 2007 – Cardiac and cerebral vascular diseases are leading causes of morbidity and death in solid organ transplant recipients. Immunosuppressant drugs are associated with dyslipidemia, hypertension, and hyperglycemia, which along with obesity are the main features of metabolic syndrome. In the nontransplant population, metabolic syndrome is associated with increased risk for major vascular complications.
Reconstructing the drainage vein of the right paramedian sector in right liver grafts
Yasuhiko Sugawara, Sumihito Tamura – 30 July 2007
MARS dialysis in decompensated alcoholic liver disease: A single‐center experience
Birger Wolff, Klaus Machill, Detlef Schumacher, Ilona Schulzki – 30 July 2007 – Acute decompensation of chronically stable alcoholic liver disease (ALD) is the most common cause of terminal liver failure in developed countries. Molecular adsorbent recirculation system (MARS) is increasingly used as artificial liver support to facilitate spontaneous organ recovery. However, the experience to date and the evidence to justify this therapeutic strategy in acutely decompensated ALD are still insufficient.